Correlation Between Sinphar Pharmaceutical and Universal Vision
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Universal Vision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Universal Vision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Universal Vision Biotechnology, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Universal Vision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Universal Vision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Universal Vision.
Diversification Opportunities for Sinphar Pharmaceutical and Universal Vision
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sinphar and Universal is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Universal Vision Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Vision Bio and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Universal Vision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Vision Bio has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Universal Vision go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and Universal Vision
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the Universal Vision. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 3.39 times less risky than Universal Vision. The stock trades about 0.0 of its potential returns per unit of risk. The Universal Vision Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 26,331 in Universal Vision Biotechnology on August 30, 2024 and sell it today you would lose (5,231) from holding Universal Vision Biotechnology or give up 19.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. Universal Vision Biotechnology
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| Universal Vision Bio |
Sinphar Pharmaceutical and Universal Vision Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and Universal Vision
The main advantage of trading using opposite Sinphar Pharmaceutical and Universal Vision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Universal Vision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Vision will offset losses from the drop in Universal Vision's long position.| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
| Universal Vision vs. Sinphar Pharmaceutical Co | Universal Vision vs. Grape King Bio | Universal Vision vs. Apex Biotechnology Corp | Universal Vision vs. Leatec Fine Ceramics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |